Date Time
Promising malaria vaccine enters final stage of clinical testing in West Africa
R21/Matrix-M becomes the second malaria vaccine candidate ever to start a phase III licensure trial
This builds on the recent finding of high level efficacy of this vaccine in a phase IIb trial in children in Burkina Faso, published today in The Lancet
The first phase III trial doses were administered by the team at the Malaria Research and Training Centre, Bamako, Mali, one of five trial sites across West and East Africa
The malaria vaccine was designed at the Jenner Institute, University of Oxford, who have partnered with the Serum Institute of India for commercial development
It will be months before there is consensus over COVID-19 vaccine patents: Experts downtoearth.org.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from downtoearth.org.in Daily Mail and Mail on Sunday newspapers.
COVID-19: Plea in HC to waive clinical trials of foreign vaccines
SECTIONS
Last Updated: May 04, 2021, 12:29 PM IST
Share
Synopsis
A bench of Chief Justice D N Patel and Justice Jasmeet Singh said it will hear the matter on May 13 as issues raised in the petition are already being considered by the Supreme Court which has also passed a detailed order regarding the same on April 30.
Ahluwalia also told the bench that the apex court was going to hear the matter again on May 10.
A PIL in the Delhi High Court on Tuesday sought a direction to the Centre to waive clinical trials of foreign vaccines so that they are available for use without any delay and to give priority in vaccination to those who have already taken the first dose. A bench of Chief Justice D N Patel and Justice Jasmeet Singh, however, said it will hear the matter on May 13 as issues raised in the petition are already being considered by the Supreme Court which has also passed a detailed order regarding the same on
COVID-19: Plea in Delhi HC to waive clinical trials of foreign vaccines
The court decided to adjourn the matter after the central government standing counsel Anurag Ahluwalia, appearing for the Union Health Ministry, said a similar issue was before the Supreme Court.
Share Via Email
| A+A A- By PTI
NEW DELHI: A PIL in the Delhi High Court on Tuesday sought a direction to the Centre to waive clinical trials of foreign vaccines so that they are available for use without any delay and to give priority in vaccination to those who have already taken the first dose.
A bench of Chief Justice D N Patel and Justice Jasmeet Singh, however, said it will hear the matter on May 13 as issues raised in the petition are already being considered by the Supreme Court which has also passed a detailed order regarding the same on April 30.
0
Serum Institute of India Pvt Ltd (SII), the Covishield vaccine maker, is working very closely with the Indian government and so far, it had supplied 15 crore doses out of total order of 26 crore doses, says, Adar C Poonawalla, chief executive (CEO) of SII. He was responding to media reports that claimed the last order placed with the two vaccine makers, 100 million doses with SII and 20 million doses with Bharat Biotech was in March this year.
In a statement, he says, Amongst multiple reports it is important that correct information be shared with the public. Vaccine manufacturing is a specialised process, it is therefore not possible to ramp up production overnight. We also need to understand that the population of India is huge and to produce enough doses for all adults is not an easy task. Even the most advanced countries and companies are struggling in relatively smaller populations.